Balyasny Asset Management
BDSX icon

Balyasny Asset Management’s Biodesix BDSX Stock Holding History

Balyasny Asset Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,017
Closed -$225K – 2901
2025
Q4 		$225K Sell
33,017
-10,007
-23% -$73.7K ﹤0.01% 2846
2025
Q3 		$325K Buy
43,024
+48
+0.1% +$369 ﹤0.01% 2552
2025
Q2 		$243K Buy
+42,976
New +$347K ﹤0.01% 2538
2025
Q1 		– Sell
-959
Closed -$29.3K – 2792
2024
Q4 		$29.3K Buy
+959
New +$28.2K ﹤0.01% 2651

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Balyasny Asset Management's BDSX Position: Q1 2026 in Review

Balyasny Asset Management sold out of Biodesix (BDSX) in Q1 2026, closing a stake of 33,017 shares — an estimated $225K sold.

Balyasny Asset Management first reported a position in BDSX in Q4 2024 and held it in 4 quarters. The position peaked at $325K in Q3 2025. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Balyasny Asset Management reported no remaining Biodesix position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 33,017 Biodesix shares in Q1 2026, an estimated $225K.
  • Balyasny Asset Management first reported a position in Biodesix in Q4 2024 and held it in 4 quarters.
  • Balyasny Asset Management's Biodesix position peaked at $325K in Q3 2025.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.